You are searching for: Phase 2 Trial

Drug Name Acalabrutinib
Drug Type Small molecular drug
Drug Status Phase 2 Trial
Disease Coronavirus Disease 2019 (COVID-19)
TTD Drug ID D08ABQ Drug Info
Drug Name Sirolimus
Drug Type Small molecular drug
Drug Status Phase 2 Trial
Disease Coronavirus Disease 2019 (COVID-19)
TTD Drug ID D07ALX Drug Info
Drug Name Duvelisib
Drug Type Small molecular drug
Drug Status Phase 2 Trial
Disease Coronavirus Disease 2019 (COVID-19)
TTD Drug ID D06ZVZ Drug Info
Drug Name Camostat mesylate
Drug Type Small molecular drug
Drug Status Phase 2/3 Trial
Disease Coronavirus Disease 2019 (COVID-19) ; Middle East Respiratory Syndrome (MERS)
TTD Drug ID D0A5BT Drug Info
No Structure Available Drug Name BLD-2660
Drug Type Small molecular drug
Drug Status Phase 2 Trial
Disease Coronavirus Disease 2019 (COVID-19)
TTD Drug ID D08JHZ Drug Info
No Structure Available Drug Name LY3127804
Drug Type Monoclonal antibody
Drug Status Phase 2 Trial
Disease Coronavirus Disease 2019 (COVID-19)
TTD Drug ID D04KTI Drug Info
No Structure Available Drug Name Avdoralimab
Drug Type Monoclonal antibody
Drug Status Phase 2 Trial
Disease Coronavirus Disease 2019 (COVID-19)
TTD Drug ID D03EHN Drug Info
No Structure Available Drug Name Leronlimab
Drug Type Monoclonal antibody
Drug Status Phase 2 Trial
Disease Coronavirus Disease 2019 (COVID-19)
TTD Drug ID D0HN8P Drug Info
No Structure Available Drug Name Eculizumab
Drug Type Monoclonal antibody
Drug Status Phase 2 Trial
Disease Coronavirus Disease 2019 (COVID-19)
TTD Drug ID D08SPH Drug Info
No Structure Available Drug Name Otilimab
Drug Type Monoclonal antibody
Drug Status Phase 2 Trial
Disease Coronavirus Disease 2019 (COVID-19)
TTD Drug ID D04GWO Drug Info

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.